Paper3472076
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa.
Clavel F and 8 others. N Engl J Med, 1987. Cited by 288 papers, by iCite.
Cite this record
ConductScience Library. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. Papers, record 3472076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3472076
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| AIDS-Related Complex | |
| Africa, Western | |
| Antibodies, Viral | |
| Cross Reactions | |
| Female | |
| HIV | |
| HIV Antibodies | |
| Humans | |
| Male |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02401555 | Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay | Background |
Source ClinicalTrials.gov
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 288 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42306115 | HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population. | Infez Med | 2026 | https://conductscience.org/library/papers/42306115 | PubMed |
| 38469363 | HIV and COVID-19: two pandemics with significant (but different) central nervous system complications. | Free Neuropathol | 2024 | https://conductscience.org/library/papers/38469363 | PubMed |
| 38215691 | Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans. | EBioMedicine | 2024 | https://conductscience.org/library/papers/38215691 | PubMed |
| 35476802 | Novel assays to investigate the mechanisms of latent infection with HIV-2. | PLoS One | 2022 | https://conductscience.org/library/papers/35476802 | PubMed |
| 30949532 | Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/30949532 | PubMed |
| 28588579 | Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections. | Front Immunol | 2017 | https://conductscience.org/library/papers/28588579 | PubMed |
| 27878297 | Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27878297 | PubMed |
| 27795437 | A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. | J Virol | 2017 | https://conductscience.org/library/papers/27795437 | PubMed |
| 25473058 | Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes. | J Virol | 2015 | https://conductscience.org/library/papers/25473058 | PubMed |
| 23824279 | Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. | PLoS One | 2013 | https://conductscience.org/library/papers/23824279 | PubMed |
| 22770231 | Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa. | BMC Pediatr | 2012 | https://conductscience.org/library/papers/22770231 | PubMed |
| 21159859 | Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. | J Virol | 2011 | https://conductscience.org/library/papers/21159859 | PubMed |
| 19936055 | Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease. | PLoS Pathog | 2009 | https://conductscience.org/library/papers/19936055 | PubMed |
| 18304321 | Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. | BMC Infect Dis | 2008 | https://conductscience.org/library/papers/18304321 | PubMed |
| 15613310 | Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G. | J Virol | 2005 | https://conductscience.org/library/papers/15613310 | PubMed |
| 11996677 | Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. | Emerg Infect Dis | 2002 | https://conductscience.org/library/papers/11996677 | PubMed |
| 11312337 | DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. | J Virol | 2001 | https://conductscience.org/library/papers/11312337 | PubMed |
| 11160733 | GLI-2 modulates retroviral gene expression. | J Virol | 2001 | https://conductscience.org/library/papers/11160733 | PubMed |
| 8793396 | Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group. | Eur J Clin Microbiol Infect Dis | 1996 | https://conductscience.org/library/papers/8793396 | PubMed |
| 8676486 | Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein. | J Virol | 1996 | https://conductscience.org/library/papers/8676486 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3472076
GET https://conductscience.org/api/papers/v1/3472076/cited_by?page=2